An aggressive breast cancer lacking common drug targets, triple-negative breast cancer may be countered by oridonin, a ...

Circadian rhythms are endogenous oscillations widely present in living organisms, typically following approximately 24-hour ...

Roche’s long-stuttering attempt to bring the cancer drug candidate ipatasertib to market has run out of steam. After multiple clinical setbacks, the Swiss pharma giant has dropped (PDF) a phase 3 ...

Vaderis Therapeutics’ goal to develop the first drug aimed specifically at a certain rare blood vessel disorder came one step closer today with the news that the therapy is safe and reduced nosebleeds ...